ArticleScientific reports2017

H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer.

S Mazzucchelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.